Umberto Malapelle

About Umberto Malapelle

Umberto Malapelle, With an exceptional h-index of 48 and a recent h-index of 42 (since 2020), a distinguished researcher at Università degli Studi di Napoli Federico II, specializes in the field of Predictive Molecular Pathology.

His recent articles reflect a diverse array of research interests and contributions to the field:

53P MET exon 14 skipping mutations in non-small cell lung cancer: Real-world data from the Italian biomarker ATLAS database

1231 A novel scoring system to predict PARP inhibitors efficacy in ovarian cancer patients undergoing neoadjuvant chemotherapy: findings from an Italian tertiary-care center

Biomarker testing in patients with advanced non-small cell lung cancer: the never-ending story

Technical evaluation of a novel digital PCR platform for detecting EGFR/KRAS mutations in NSCLC archived plasma specimens

PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories

Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis

Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems

The role of liquid biopsy in epithelial ovarian cancer: state of the art

Umberto Malapelle Information

University

Position

Department of Public Health

Citations(all)

7317

Citations(since 2020)

5819

Cited By

3126

hIndex(all)

48

hIndex(since 2020)

42

i10Index(all)

158

i10Index(since 2020)

136

Email

University Profile Page

Google Scholar

Umberto Malapelle Skills & Research Interests

Predictive Molecular Pathology

Top articles of Umberto Malapelle

53P MET exon 14 skipping mutations in non-small cell lung cancer: Real-world data from the Italian biomarker ATLAS database

ESMO Open

2024/3/1

1231 A novel scoring system to predict PARP inhibitors efficacy in ovarian cancer patients undergoing neoadjuvant chemotherapy: findings from an Italian tertiary-care center

2024/3/1

Umberto Malapelle
Umberto Malapelle

H-Index: 28

Biomarker testing in patients with advanced non-small cell lung cancer: the never-ending story

The Lancet Regional Health–Europe

2024/3/1

Umberto Malapelle
Umberto Malapelle

H-Index: 28

Technical evaluation of a novel digital PCR platform for detecting EGFR/KRAS mutations in NSCLC archived plasma specimens

The Journal of Liquid Biopsy

2024/3/1

Alessandro Russo
Alessandro Russo

H-Index: 24

Umberto Malapelle
Umberto Malapelle

H-Index: 28

PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories

Pharmacogenomics

2024/2

Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis

Healthcare

2024/1/19

Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems

Heliyon

2024/1/15

The role of liquid biopsy in epithelial ovarian cancer: state of the art

2024/1/11

A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers

Clinical and Experimental Medicine

2024/4/10

Economic assessment of NGS testing workflow for NSCLC in a healthcare setting

Heliyon

2024/4/5

The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database

Lung Cancer

2024/4/5

Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: are we on the right path?

2024/4/4

Paolo Ruggeri
Paolo Ruggeri

H-Index: 4

Umberto Malapelle
Umberto Malapelle

H-Index: 28

Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance

2024/1/4

Umberto Malapelle
Umberto Malapelle

H-Index: 28

Dissecting the nuances of cancer epigenomics in liquid biopsy

Epigenomics

2024/1

Umberto Malapelle
Umberto Malapelle

H-Index: 28

OC. 04.3: BRANCHED DNA MOLECULAR TRIAGE OF FIT+ PATIENTS

Digestive and Liver Disease

2024/4/1

BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report

2024/4

Digital counting of tissue cells for molecular analysis: the QuANTUM pipeline

Virchows Archiv

2024/3/26

Catarina Eloy
Catarina Eloy

H-Index: 18

Umberto Malapelle
Umberto Malapelle

H-Index: 28

Sotorasib in KRASp. G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program

Lung Cancer

2024/1/1

Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing

Journal of Personalized Medicine

2024/3/22

See List of Professors in Umberto Malapelle University(Università degli Studi di Napoli Federico II)

Co-Authors

academic-engine